News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agenus (AGEN) To Present At The 4th Annual Cancer Immunotherapy Conference


3/26/2014 7:27:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Agenus Inc. (Nasdaq: AGEN) today announced that Robert Stein, MD, PhD, Chief Scientific Officer of Agenus, will be presenting on Agenus’ checkpoint modulator portfolio and immuno-oncology strategy at the 4th Annual Cancer Immunotherapy Conference at the New York Academy of Medicine in New York City. On March 27, 2014, a presentation on Checkpoint Modulators is scheduled for 8:30 am Eastern Time and a corporate presentation is scheduled for 2:15 pm Eastern Time.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES